Heterocyclic Curcumin Derivatives of Pharmacological Interest: Recent Progress

Author(s): Maximiliano Martinez-Cifuentes, Boris Weiss-Lopez, Leonardo S. Santos, Ramiro Araya-Maturana

Journal Name: Current Topics in Medicinal Chemistry

Volume 15 , Issue 17 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Curcumin, a natural yellow polyphenol, is isolated from the herb Curcuma longa L. (turmeric), a member of the ginger family. It has been extensively studied due to their multiple pharmacological properties. Nevertheless, curcumin has disadvantages such as poor water solubility, poor bioavailability and rapid metabolism, which has prompted the search for analogues that overcome these shortcomings while maintaining or improving their good pharmacological properties. Among the main curcumin analogues that have been developed, the heterocyclic curcuminoids show a high interest. In this review, we describe recent progress in the synthesis and pharmacological properties of new heterocyclic curcumin derivatives. The most recent developments in anti-cancer, anti-Alzheimer, anti-bacterial and anti-oxidants heterocyclic curcumin derivatives are covered.

Keywords: Alzheimer, Antibacterial, Antioxidants, Curcumin, Cancer, Heterocycles.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 03 June, 2015
Page: [1663 - 1672]
Pages: 10
DOI: 10.2174/1568026615666150427111837
Price: $65

Article Metrics

PDF: 54